Excellergy has emerged with $70 million and an investigative drug class in its portfolio, part of its ambitious mission to ...

The U.S. government has agreed to loan privately-held biotechnology firm Ginkgo Bioworks $1.1 billion for COVID-19 testing and the production of raw materials for therapies that may help address ...

The administration hopes to make the TrumpRx website available in early 2026. While President Donald Trump announced on Tuesday that Pfizer, one of the leading pharmaceutical companies, had agreed to ...

Gold major Newmont on Monday named COO Natascha Viljoen as its next president and CEO, marking the first time in the company’s 104-year history that a woman will lead the world’s largest gold miner.

Barrick Mining (NYSE: B) announced the resignation of President and CEO Mark Bristow today. After nearly seven years at the helm, the South African-born mining veteran departs without explanation, ...

Walmart CEO Doug McMillon warned that AI will “change literally every job” as the retail giant looks to automate more roles and keep the size of its workforce flat over the next few years. Artificial ...

A health care private equity firm has bought Currier Plastics and named a new CEO to lead the Auburn manufacturer. Sheridan Capital Partners announced Monday that it completed its "investment" in ...

On the latest episode of The Verge's Decoder podcast, released today, Ford CEO Jim Farley told guest host Joanna Stern that the automaker does not entirely like Apple's current implementation of its ...

TotalEnergies SE and its partners are poised to restart construction of a giant liquefied natural gas project in northern Mozambique as the security situation in the region has improved, the chief ...

Comcast has promoted President Mike Cavanagh to the role of co-CEO alongside Brian Roberts, effective Jan. 1, 2026. In his current role, Cavanagh has managed all aspects of Comcast’s business with ...

The first woman to helm a Big Pharma will be stepping down in January as GSK’s Emma Walmsley moves aside for her chief commercial officer Luke Miels. Walmsley, 56, who became the British pharma’s CEO ...

British pharmaceutical giant GSK on Monday said longtime chief executive Emma Walmsley will be replaced by its chief commercial officer in January, as the company navigates US tariffs on the sector.